CClinicalTrials.gg
Sign In
CompletedNCT06078631ECOPERFUpdated Jan 28, 2025

Influence of Students Behaviors on Performance and Quality of Life on the OSCE

An observational study in Objective Structured Clinical Examination and Performance Anxiety, sponsored by Claude Bernard University. Completed at 1 site in France. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-01-28.

Sponsored by Claude Bernard University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
500
Ages
18 Years to 55 Years
Sex
All
01

Study summary

The students behave differentially before an exam. This study aims at determining the influence of all these behaviors on the perceived quality of life of students and their performance during their OSCE.

Read the detailed description

The students behave differentially before an exam. They can be discriminate, on their sleeping, coping, or physical activity behavior. They also show difference in the number of hours they study by weeks or if they use the services offer by their university.

This study aims at determining the influence of all these behaviors on the perceived quality of life of students and their performance during their OSCE (a major exam).

02

Conditions studied

  • Objective Structured Clinical Examination
  • Performance Anxiety

Keywords

  • stress
  • physical activity
  • sedentarity
  • sleep
  • quality of life
  • coping
03

In context

Lead sponsor

Claude Bernard University is the lead sponsor of 29 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Medical students

Inclusion criteria

  • all volontary medical students of the third cycle that came for their exam during the sessions of December and May 2023 from the University of Lyon (Medecine ESt)

Exclusion criteria

Exclusion Criteria:

  • no exclusion criteria
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
500 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. PERFORMANCE

    Score at the OSCE exam from 0 to 40 points

    Time frame: obtained 7 days after the OSCE

Secondary outcomes

  1. SF-12

    Overall quality of life

    Time frame: obtained one hour after the OSCE

07

Study locations

1 site
  • Marc lilot
    Lyon, 69003, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06078631
Lead sponsor
Claude Bernard University
Responsible party
Lilot Marc (Director, Doctor, Claude Bernard University) — Principal investigator
First posted
Oct 12, 2023
Start date
Jan 5, 2023
Primary completion
Aug 5, 2024
Completion
Aug 11, 2024
Last update
Jan 28, 2025

Study contacts

Gilles Rode, PhD
study chair · UCBL1

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Claude Bernard University

Start the discussion